Puma Biotechnology Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2007
Net Income	21.59	0	-29.13	-60	-75.6	-113.58	-291.96	-276.01	-239.28	-141.97	Upgrade
Depreciation & Amortization	11.52	9.84	11.31	10.03	8.08	7.38	2.81	1.15	0.78	0.63	Upgrade
Share-Based Compensation	10.25	11.83	32.63	36.58	57.33	86.94	108.74	117.26	94.93	39.15	Upgrade
Other Operating Activities	-16.35	-37.5	5.84	14.16	32.57	-4.85	7.94	15.91	-10.89	24.98	Upgrade
Operating Cash Flow	27.01	-15.83	20.65	0.77	22.38	-24.11	-172.47	-141.69	-154.47	-77.2	Upgrade
Operating Cash Flow Growth	-	-	2571.41%	-96.55%	-	-	-	-	-	-	Upgrade
Capital Expenditures	-0.14	0	0	-0.05	-0.31	-0.61	-0.43	-7.28	-1.18	-1.29	Upgrade
Change in Investments	-6.49	14.1	-10.88	43.45	5.47	-57.01	35	149.47	-81.58	-61.98	Upgrade
Other Investing Activities	-12.5	-7	-	-10	-	-	-50	-	-3.1	-0	Upgrade
Investing Cash Flow	-19.13	7.1	-10.88	33.4	5.16	-57.62	-15.44	142.19	-85.86	-63.28	Upgrade
Share Issuance / Repurchase	0	12.22	0	0.07	1.35	7.65	26.69	162.43	233.36	135.97	Upgrade
Debt Issued / Paid	0	0	-11.93	0	-68.42	100.8	48.43	0	0	0	Upgrade
Other Financing Activities	-	-	-20	-10	-	-	-	-	-	-	Upgrade
Financing Cash Flow	0	12.22	-31.93	-9.93	-67.07	108.45	75.11	162.43	233.36	135.97	Upgrade
Net Cash Flow	7.88	3.5	-22.16	24.24	-39.53	26.72	-112.8	162.93	-6.97	-4.51	Upgrade
Free Cash Flow	26.87	-15.83	20.65	0.73	22.07	-24.71	-172.9	-148.97	-155.65	-78.5	Upgrade
Free Cash Flow Growth	-	-	2740.44%	-96.71%	-	-	-	-	-	-	Upgrade
Free Cash Flow Margin	11.40%	-6.94%	8.16%	0.32%	8.11%	-9.85%	-624.53%	-	-	-	Upgrade
Free Cash Flow Per Share	0.57	-0.35	0.51	0.02	0.57	-0.65	-4.65	-4.47	-4.84	-2.62	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).